Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PGR | P06401 | 7/20 | 0.37 |
| ▸ | AR | P10275 | 6/20 | 0.37 |
| ▸ | NR1I2 | O75469 | 2/20 | 0.36 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.36 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.36 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.36 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.36 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.36 |
| ▸ | DRD3 | P35462 | 1/20 | 0.36 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.36 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.36 |
| ▸ | PDK1 | Q15118 | 4/20 | 0.36 |
| ▸ | PDK2 | Q15119 | 4/20 | 0.36 |
| ▸ | PDK3 | Q15120 | 4/20 | 0.36 |
| ▸ | PDK4 | Q16654 | 4/20 | 0.36 |
| ▸ | NR3C2 | P08235 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13768840 | 0.90 | PGR (0.36) | PGRARNR1I2NR3C1ADORA3 | |
| SCHEMBL13768718 | 0.79 | AR (0.45) | PGRARNR3C2 | |
| SCHEMBL13795746 | 0.78 | AR (0.37) | PGRARNR1I2NR3C1ADORA3 | |
| SCHEMBL13556656 | 0.75 | SHBG (0.44) | PGRARNR3C1SLC6A4NR3C2 | |
| SCHEMBL13769270 | 0.71 | PDK1 (0.34) | PGRARPDK1PDK2PDK3 | |
| SCHEMBL13768826 | 0.70 | — | — | |
| SCHEMBL13796902 | 0.68 | PGR (0.34) | PGRAR | |
| SCHEMBL13796510 | 0.68 | PGR (0.47) | PGRARNR3C1SLC6A4NR3C2 | |
| SCHEMBL14949843 | 0.68 | PGR (0.62) | PGRARNR1I2NR3C1ADORA3 | |
| SCHEMBL13769014 | 0.67 | PDK1 (0.35) | PGRARNR1I2NR3C1ADORA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009083269-A1 | 15,16-METHYLENE-17-HYDROXY-19-NOR-21-CARBOXYLIC ACID γ-LACTONE DERIVATIVE, USE THEREOF, AND MEDICAMENT CONTAINING SAID DERIVATIVE | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2009-07-09 | — | — | WO | disclosed |